Abstract
Pedunculated skin lesions frequently appear as peculiar morphologies of varying sizes and locations. These lesions are rare but have many forms. Some lesions have not been fully described and can be confusing. The pedunculated lesion pattern is a subcategory of all cutaneous neurofibroma types. Sporadic pedunculated lesions are often the result of mutations in the neurofibromin 1 of certain cells. We report a case of pedunculated neurofibroma of the left thigh in an adult woman. The lesion was treated surgically without complications. The issue of diagnosis and management of cutaneous neurofibroma is under active research. Through this case, we also update the literature on issues related to cutaneous neurofibroma. Current research directions include planning to establish new classification systems, devising suitable diagnostic methods, and developing optimal therapeutics based on molecular biology, gene therapy, and stem cells.
Similar content being viewed by others
Data availability
This is not applicable.
Code Availability
This is not applicable.
References
Skuse GR, Kosciolek BA, Rowley PT. The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin. Am J Hum Genet. 1991;49(3):600–7.
Lammert M, Friedman JM, Kluwe L, Mautner VF. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol. 2005;141(1):71–4. https://doi.org/10.1001/archderm.141.1.71.
Messersmith L, Krauland K. Neurofibroma. [updated 2022 Aug 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2023. Available from https://www.ncbi.nlm.nih.gov/books/NBK539707. Accessed 29 May 2023.
Ortonne N, Wolkenstein P, Blakeley JO, Korf B, Plotkin SR, Riccardi VM, et al. Cutaneous neurofibromas: current clinical and pathologic issues. Neurology. 2018;91(2 Suppl 1):S5–S13. https://doi.org/10.1212/WNL.0000000000005792.
Wollina U, Goldman A. Giant pedunculated tumors of skin. Georgian Med News. 2020;(301):44–9.
Nagrani NS, Bhawan J. Histopathological variants of cutaneous neurofibroma: a compendious review. Dermatopathology (Basel). 2022;10(1):1–19. https://doi.org/10.3390/dermatopathology10010001.
Cannon A, Chen MJ, Li P, Boyd KP, Theos A, Redden DT, et al. Cutaneous neurofibromas in neurofibromatosis type I: a quantitative natural history study. Orphanet J Rare Dis. 2018;13(1):31. https://doi.org/10.1186/s13023-018-0772-z.
Santos A, Geller M, Mezitis S, Rubenstein AE, Oliveira L, Medeiros Lima DJ, et al. Determination of vitamin D levels in patients with neurofibromatosis type 1 in the pediatric age group. Clin Pathol. 2020;13:2632010X20928930. https://doi.org/10.1177/2632010X20928930.
Kanno DT, Mattos RLM, Campos FG, Siqueira RM, Carvalho RB, Real Martinez CA. Multiple neuroendocrine neoplasia in a patient with type I neurofibromatosis (NF1): report of a new mutation (NF1, exons 2-30 deletion) and literature review. Arq Bras Cir Dig. 2023;35:e1702. https://doi.org/10.1590/0102-672020220002e1702.
Ge LL, Xing MY, Zhang HB, Wang ZC. Neurofibroma development in neurofibromatosis type 1: insights from cellular origin and schwann cell lineage development. Cancers (Basel). 2022;14(18):4513. https://doi.org/10.3390/cancers14184513.
Scala M, Schiavetti I, Madia F, Chelleri C, Piccolo G, Accogli A, et al. Genotype-phenotype correlations in neurofibromatosis type 1: a single-center cohort study. Cancers (Basel). 2021;13(8):1879. https://doi.org/10.3390/cancers13081879.
Guiraud M, Bouroubi A, Beauchamp R, Bocquet A, Grégoire JM, Rauly-Lestienne I, et al. Cutaneous neurofibromas: patients’ medical burden, current management and therapeutic expectations: results from an online European patient community survey. Orphanet J Rare Dis. 2019;14(1):286. https://doi.org/10.1186/s13023-019-1265-4.
Jouhilahti EM, Peltonen S, Callens T, Jokinen E, Heape AM, Messiaen L, et al. The development of cutaneous neurofibromas. Am J Pathol. 2011;178(2):500–5. https://doi.org/10.1016/j.ajpath.2010.10.041.
Amaravathi A, Oblinger JL, Welling DB, Kinghorn AD, Chang LS. Neurofibromatosis: molecular pathogenesis and natural compounds as potential treatments. Front Oncol. 2021;11:698192. https://doi.org/10.3389/fonc.2021.698192.
Li S, Chen Z, Le LQ. New insights into the neurofibroma tumor cells of origin. Neurooncol Adv. 2019;2(Suppl 1):i13–22. https://doi.org/10.1093/noajnl/vdz044.
Lim R, Jaramillo D, Poussaint TY, Chang Y, Korf B. Superficial neurofibroma: a lesion with unique MRI characteristics in patients with neurofibromatosis type 1. AJR Am J Roentgenol. 2005;184(3):962–8. https://doi.org/10.2214/ajr.184.3.01840962.
Raffin D, Zaragoza J, Georgescou G, Mourtada Y, Maruani A, Ossant F, et al. High-frequency ultrasound imaging for cutaneous neurofibroma in patients with neurofibromatosis type I. Eur J Dermatol. 2017;27(3):260–5. https://doi.org/10.1684/ejd.2017.3015.
Adeniji-Sofoluwe AT, Ogunleye OA, Okolo CA. MRI evaluation of diffuse subcutaneous neurofibroma of the lower limb in a low resource setting. BJR Case Rep. 2017;4(2):20170090. https://doi.org/10.1259/bjrcr.20170090.
Meyer A, Billings SD. What's new in nerve sheath tumors. Virchows Arch. 2020;476(1):65–80. https://doi.org/10.1007/s00428-019-02671-0.
Acar S, Nieblas-Bedolla E, Armstrong AE, Hirbe AC. A systematic review of recent and ongoing clinical trials in patients with the neurofibromatoses. Pediatr Neurol. 2022;134:1–6. https://doi.org/10.1016/j.pediatrneurol.2022.06.003.
Ahlawat S, Blakeley JO, Langmead S, Belzberg AJ, Fayad LM. Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Skeletal Radiol. 2020;49(2):199–219. https://doi.org/10.1007/s00256-019-03290-1.
Chamseddin BH, Le LQ. Management of cutaneous neurofibroma: current therapy and future directions. Neurooncol Adv. 2019;2(Suppl 1):i107–16. https://doi.org/10.1093/noajnl/vdz034.
Sanchez LD, Bui A, Klesse LJ. Targeted therapies for the neurofibromatoses. Cancers (Basel). 2021;13(23):6032. https://doi.org/10.3390/cancers13236032.
Author information
Authors and Affiliations
Contributions
VTH, THH, and MHL collected the data and wrote the manuscript. HATV and NNTL reviewed and revised the manuscript. All authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
This is not applicable.
Consent to Participate
Consent to participate was obtained from all authors.
Written Consent for Publication
Written informed consent was obtained from the patient.
Conflicts of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Imaging
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hoang, V.T., Hoang, T.H., Van, H.A.T. et al. Pedunculated Cutaneous Neurofibroma: a Case Report and Literature Review. SN Compr. Clin. Med. 5, 153 (2023). https://doi.org/10.1007/s42399-023-01494-0
Accepted:
Published:
DOI: https://doi.org/10.1007/s42399-023-01494-0